Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir

Autor: Guna Proboka, Andra Tilgase, Sergejs Isajevs, Tatjana Zablocka, Evija Olmane, Agnija Rasa, Pēteris Alberts

Publikováno v: Case Reports in Oncology, Vol 13, Iss 1, Pp 424-430 (2020)

Adrenal gland melanoma is an extremely rare diagnosis with less than 20 cases reported. The criteria for diagnosing adrenal gland melanoma include involvement of only one adrenal gland, presence of melanin pigment in the histological examination of t

Externí odkaz: https://doaj.org/article/4f0c9f7c4f91402092028ac08cd6b7a1

A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report

Autor: Vladimirs Sorokins, Andra Tilgase, Evija Olmane, Sergejs Isajevs, Tatjana Zablocka, Agnija Rasa, Pēteris Alberts

Publikováno v: SAGE Open Medical Case Reports, Vol 8 (2020)

Melanoma is an aggressive skin cancer form with a grave prognosis. Current results suggest that oncolytic virus treatment of melanoma has a high therapeutic potential. ECHO-7 (Rigvir) is the first oncolytic virus registered in Latvia. A female patien

Externí odkaz: https://doaj.org/article/e9b8b1e273224bc9881c97a2965d4740

Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report

Autor: Simona Doniņa, Ineta Nemiro, Elizabete Pumpure, Pēteris Alberts, Raimundas Meskauskas, Agnija Rasa, Dana Kigitoviča, Tatjana Zablocka, Evija Olmane, Sergejs Isajevs, Eva Dručka

Publikováno v: Clinical Case Reports, Vol 8, Iss 8, Pp 1538-1543 (2020)
Clinical Case Reports

Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression‐free survival are good.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67af5a19198920d8201ab786cf894811
https://doaj.org/article/b5343f8dc6e245e9b9688295ac08bda0

Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient

Autor: Agnija Rasa, Pēteris Alberts, Linda Brokāne, Andra Tilgase, Donatas Petroška, Evija Olmane, Inta Jaunalksne

Publikováno v: Clinical Case Reports, Vol 7, Iss 6, Pp 1191-1196 (2019)
Clinical case reports, Hoboken : Wiley-Blackwell Publishing Ltd, 2019, vol. 7, no. 6, p. 1191-1196
Clinical Case Reports

A 35‐year‐old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f41a996c5fa4926bcdddf263fe86b89
https://doaj.org/article/a3498975670446ecb292bde6385c8f1f

Fatty liver indexandhepatic steatosis index for prediction ofnon-alcoholic fatty liver disease in type 1 diabetes

Autor: Zane Dzērve, Kārlis Kupčs, Jeļizaveta Sokolovska, Valdis Pīrāgs, Evija Olmane, Laura Sviklāne

Publikováno v: Journal of Gastroenterology and Hepatology. 33:270-276

Background and Aim Little is known about the diagnostic value of hepatic steatosis index (HSI) and fatty liver index (FLI), as well as their link to metabolic syndrome in type 1 diabetes mellitus. We have screened the effectiveness of FLI and HSI in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1be97f76d37ebfe6cf606c871a5e5a20
https://doi.org/10.1111/jgh.13814